R. Nave - Concepedia

Author

R. Nave

Altana (Netherlands)

Also Known As

R NAVE, R Nave, R. Nave, Rüdiger Nave

Publications

878

Citations

H-Index

Concepts

All Affiliations

Altana (Netherlands)Bayer (Germany)University of Florida Teijin (Japan)

About

R. Nave is an author at Altana (Netherlands) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	207
2	Allergy	2	2	20
3	Health Sciences	1	1	28
4	Natural Sciences	1	1	14
5	Allergy Medicine	1	1	10

R. Nave

Publications

509

Citations

H-Index

Page 1

	Year	Citations
Population Pharmacokinetics and Pharmacodynamics of Ciclesonide Shashank Rohatagi, Vikram Arya, Karl Zech, The Journal of Clinical Pharmacology	2003	105
Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide R. Nave, Wally Meyer, Rainer Fuhst, Pulmonary Pharmacology & Therapeutics Lung InflammationMedicineRespiratory ToxicologyPhysiologyPulmonary Pharmacology	2005	81
PK/PD of inhaled corticosteroids: The risk/benefit of inhaled ciclesonide Shashank Rohatagi, Hartmut Derendorf, Karl Zech, Journal of Allergy and Clinical Immunology Respiratory ToxicologyMedicinePulmonary PharmacologyPulmonary MedicinePharmacology	2003	32
Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial Marcus‐Hillert Schultze‐Mosgau, K. Waellnitz, R. Nave, Human Reproduction	2016	31
Identification of enzymes involved in Phase I metabolism of ciclesonide by human liver microsomes Caroline Peet, T. Enos, R. Nave, European Journal of Drug Metabolism and Pharmacokinetics BiochemistryLiver PhysiologyBioanalysisMolecular BiologyHuman Liver Microsomes	2005	28
Deposition and metabolism of inhaled ciclesonide in the human lung R. Nave, Henrik Watz, Hans Hoffmann, European Respiratory Journal	2010	24
Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar R. Nave, Kulasiri A. Gunawardena, Karl Zech, International Journal of Clinical Pharmacology and Therapeutics	2006	22
Model‐Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms Isabel Reinecke, Marcus‐Hillert Schultze‐Mosgau, R. Nave, The Journal of Clinical Pharmacology	2016	22
Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549) Takashi Nonaka, R. Nave, Nigel McCracken, BMC Pharmacology	2007	21
Population Pharmacokinetics and Pharmacodynamics of Inhaled Ciclesonide and Fluticasone Propionate in Patients With Persistent Asthma Jian Xu, R. Nave, Gëzim Lahu, The Journal of Clinical Pharmacology	2010	19

Page 1